Abstract
The developmental changes in caffeine elimination were studied in 7 infants aged between 2 1/2 weeks and 6 months. Adult plasma clearance rate of caffeine was achieved at 3 to 4 1/2 months of age. Plasma half-life and elimination rate reached adult levels after 3 to 4 1/2 months and seemed to exceed adult capacity thereafter. No significant changes in apparent volume of distribution were noted. Our data provide some indication of the age in infancy when the low rates of caffeine elimination in the neonate increase to the adult rate.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aldridge A., Aranda J. V., Neims A. H. Caffeine metabolism in the newborn. Clin Pharmacol Ther. 1979 Apr;25(4):447–453. doi: 10.1002/cpt1979254447. [DOI] [PubMed] [Google Scholar]
- Aranda J. V., Cook C. E., Gorman W., Collinge J. M., Loughnan P. M., Outerbridge E. W., Aldridge A., Neims A. H. Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. J Pediatr. 1979 Apr;94(4):663–668. doi: 10.1016/s0022-3476(79)80047-5. [DOI] [PubMed] [Google Scholar]
- Aranda J. V., Gorman W., Bergsteinsson H., Gunn T. Efficacy of caffeine in treatment of apnea in the low-birth-weight infant. J Pediatr. 1977 Mar;90(3):467–472. doi: 10.1016/s0022-3476(77)80718-x. [DOI] [PubMed] [Google Scholar]
- Aranda J. V., MacLeod S. M., Renton K. W., Eade N. R. Hepatic microsomal drug oxidation and electron transport in newborn infants. J Pediatr. 1974 Oct;85(4):534–542. doi: 10.1016/s0022-3476(74)80465-8. [DOI] [PubMed] [Google Scholar]
- Aranda J. V., Sitar D. S., Parsons W. D., Loughnan P. M., Neims A. H. Pharmacokinetic aspects of theophylline in premature newborns. N Engl J Med. 1976 Aug 19;295(8):413–416. doi: 10.1056/NEJM197608192950803. [DOI] [PubMed] [Google Scholar]
- Bory C., Baltassat P., Porthault M., Bethenod M., Frederich A., Aranda J. V. Metabolism of theophylline to caffeine in premature newborn infants. J Pediatr. 1979 Jun;94(6):988–993. doi: 10.1016/s0022-3476(79)80246-2. [DOI] [PubMed] [Google Scholar]
- Burg A. W. Physiological disposition of caffeine. Drug Metab Rev. 1975;4(2):199–228. doi: 10.3109/03602537508993756. [DOI] [PubMed] [Google Scholar]
- CORNISH H. H., CHRISTMAN A. A. A study of the metabolism of theobromine, theophylline, and caffeine in man. J Biol Chem. 1957 Sep;228(1):315–323. [PubMed] [Google Scholar]
- Cook C. E., Tallent C. R., Amerson E. W., Myers M. W., Kepler J. A., Taylor G. F., Christensen H. D. Caffeine in plasma and saliva by a radioimmunoassay procedure. J Pharmacol Exp Ther. 1976 Dec;199(3):679–686. [PubMed] [Google Scholar]
- Horning M. G., Butler C. M., Howlin J., Hill R. M. Drug metabolism in the human neonate. Life Sci. 1975 Mar 1;16(5):651–671. doi: 10.1016/0024-3205(75)90343-4. [DOI] [PubMed] [Google Scholar]
- Jalling B. Plasma concentrations of phenobarbital in the treatment of seizures in newborns. Acta Paediatr Scand. 1975 May;64(3):514–524. doi: 10.1111/j.1651-2227.1975.tb03873.x. [DOI] [PubMed] [Google Scholar]
- Loughnan P. M., Greenwald A., Purton W. W., Aranda J. V., Watters G., Neims A. H. Pharmacokinetic observations of phenytoin disposition in the newborn and young infant. Arch Dis Child. 1977 Apr;52(4):302–309. doi: 10.1136/adc.52.4.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Loughnan P. M., Sitar D. S., Ogilvie R. I., Eisen A., Fox Z., Neims A. H. Pharmacokinetic analysis of the disposition of intravenous theophylline in young children. J Pediatr. 1976 May;88(5):874–879. doi: 10.1016/s0022-3476(76)81136-5. [DOI] [PubMed] [Google Scholar]
- Neims A. H., Warner M., Loughnan P. M., Aranda J. V. Developmental aspects of the hepatic cytochrome P450 monooxygenase system. Annu Rev Pharmacol Toxicol. 1976;16:427–445. doi: 10.1146/annurev.pa.16.040176.002235. [DOI] [PubMed] [Google Scholar]
- Ogilvie R. I. Clinical pharmacokinetics of theophylline. Clin Pharmacokinet. 1978 Jul-Aug;3(4):267–293. doi: 10.2165/00003088-197803040-00002. [DOI] [PubMed] [Google Scholar]
- Painter M. J., Pippenger C., MacDonald H., Pitlick W. Phenobarbital and diphenylhydantoin levels in neonates with seizures. J Pediatr. 1978 Feb;92(2):315–319. doi: 10.1016/s0022-3476(78)80034-1. [DOI] [PubMed] [Google Scholar]
- Parsons W. D., Neims A. H. Effect of smoking on caffeine clearance. Clin Pharmacol Ther. 1978 Jul;24(1):40–45. doi: 10.1002/cpt197824140. [DOI] [PubMed] [Google Scholar]
- Pelkonen O., Kaltiala E. H., Larmi T. K., Kärki N. T. Comparison of activities of drug-metabolizing enzymes in human fetal and adult livers. Clin Pharmacol Ther. 1973 Sep-Oct;14(5):840–846. doi: 10.1002/cpt1973145840. [DOI] [PubMed] [Google Scholar]
- Piafsky K. M., Sitar D. S., Ogilvie R. I. Effect of phenobarbital on the disposition of intravenous theophylline. Clin Pharmacol Ther. 1977 Sep;22(3):336–339. doi: 10.1002/cpt1977223336. [DOI] [PubMed] [Google Scholar]
- Thomas P. E., Lu A. Y., Ryan D., West S. B., Kawalek J., Levin W. Multiple forms of rat liver cytochrome P-450. Immunochemical evidence with antibody against cytochrome P-448. J Biol Chem. 1976 Mar 10;251(5):1385–1391. [PubMed] [Google Scholar]
- Welch R. M., Hsu S. Y., DeAngelis R. L. Effect of Aroclor 1254, phenobarbital, and polycyclic aromatic hydrocarbons on the plasma clearance of caffeine in the rat. Clin Pharmacol Ther. 1977 Nov;22(5 Pt 2):791–798. doi: 10.1002/cpt1977225part2791. [DOI] [PubMed] [Google Scholar]
- Wettrell G., Andersson K. E. Clinical pharmacokinetics of digoxin in infants. Clin Pharmacokinet. 1977 Jan-Feb;2(1):17–31. doi: 10.2165/00003088-197702010-00002. [DOI] [PubMed] [Google Scholar]
- Wettrell G. Distribution and elimination of digoxin in infants. Eur J Clin Pharmacol. 1977;11(5):329–335. doi: 10.1007/BF00566529. [DOI] [PubMed] [Google Scholar]
